and two-dimensional PDE to examine how the epicenter moves in space and time under different assumptions about the speed and direction of poultry. ODE Simulations showed that by reducing 95% of the initial susceptible poultry population or by culling all infected poultry birds within one day disease outbreak could control lead in a local setting. Results further elucidated that cleaning the environment is also a feasible and useful control measure, but culling wild birds and destroying their habitat are ineffective control measures. We noticed from the PDE models that the diffusion rate of the (w) has very little impact on the spread speed (1.69-1.74 km/day) where as (d) has shown substantial raise of spread speed (2-7.8 km/day) depending on the transmission direction indicating significant role of migration. Finally, we assumed that epicenter progresses dominantly along the convection direction of the domestic poultry and the disease spread to other direction via random diffusion. Mathematical modeling could prove effective in answering epidemiological issues. Additional inclusion criteria included a paid pharmacy claim for an oral antibiotic or an otic preparation within five days of the index claim. Recipients were excluded if they had multiple insurances, dual antibiotic or additional numbing agent therapy, co-morbid conditions, or concomitant infections. Recipients were also excluded if they had a medical claim for an AOE diagnosis or a prescription claim for an antibiotic or steroid during a 30-day washout period prior to the index claim. The initial pharmacy claims were grouped into five drug categories, and physicians were grouped as pediatricians, general practitioners, and other physicians. RESULTS: There were 32,059 recipients who met the initial eligibility criteria. After exclusions, a sample of 8090 recipients remained. The initial drug therapies prescribed for these recipients included topical fluoroquinolone antibiotic-steroid combination drugs (n = 2290), topical non-fluoroquinolone antibiotic-steroid combination drugs (n = 2006), otic antibiotics (n = 1406), oral antibiotics (n = 1507), and other otic preparations including acidifying agents, numbing agents, and combinations (n = 881). CONCLUSION: Topical fluoroquinolone or non-fluoroquinolone antibiotic-steroid combinations were the most frequently prescribed medications, together representing 53% of the initial therapy choices for AOE. These were followed by oral antibiotics (19%), otic antibiotics (17%), and other otic preparations (11%). Pediatricians prescribed fluoroquinolone containing combinations more frequently than general practitioners, who tended to prescribe non-fluoroquinolone containing combinations most frequently.
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PIN50 INITIAL THERAPIES FOR ACUTE OTITIS EXTERNA IN THE LOUISIANA MEDICAID POPULATION
Parmar J, Jain G, Baggarly S, Jenkins T, Lawrence L University of Louisiana at Monroe, Monroe, LA, USA OBJECTIVE: Determine the initial therapy choices for newlydiagnosed episodes of acute otitis externa (AOE) in the Louisiana Medicaid population. METHODS: Louisiana Medicaid claims were retrospectively analyzed for the period of January 1, 2004, through December 31, 2005. Recipients aged 1-64 who had a paid medical claim (index claim) with a diagnosis of AOE (ICD-9-CM codes 380.10 or 380.12) were identified in the dataset. Additional inclusion criteria included a paid pharmacy claim for an oral antibiotic or an otic preparation within five days of the index claim. Recipients were excluded if they had multiple insurances, dual antibiotic or additional numbing agent therapy, co-morbid conditions, or concomitant infections. Recipients were also excluded if they had a medical claim for an AOE diagnosis or a prescription claim for an antibiotic or steroid during a 30-day washout period prior to the index claim. The initial pharmacy claims were grouped into five drug categories, and physicians were grouped as pediatricians, general practitioners, and other physicians. RESULTS: There were 32,059 recipients who met the initial eligibility criteria. After exclusions, a sample of 8090 recipients remained. The initial drug therapies prescribed for these recipients included topical fluoroquinolone antibiotic-steroid combination drugs (n = 2290), topical non-fluoroquinolone antibiotic-steroid combination drugs (n = 2006), otic antibiotics (n = 1406), oral antibiotics (n = 1507), and other otic preparations including acidifying agents, numbing agents, and combinations (n = 881). CONCLUSION: Topical fluoroquinolone or non-fluoroquinolone antibiotic-steroid combinations were the most frequently prescribed medications, together representing 53% of the initial therapy choices for AOE. These were followed by oral antibiotics (19%), otic antibiotics (17%), and other otic preparations (11%). Pediatricians prescribed fluoroquinolone containing combinations more frequently than general practitioners, who tended to prescribe non-fluoroquinolone containing combinations most frequently.
PIN51 A PICTURE OF DEMOGRAPHIC DISPARITIES IN THE RECEIPT OF ANTIRETROVIRAL THERAPY AMONG HIV PATIENTS IN THE 2000-2005 NATIONAL AMBULATORY MEDICAL CARE SURVEYS (NAMCS)
Oramasionwu CU, Ryan L, Frei CR University of Texas at Austin and University of Texas Health Sci. Ctr. at San Antonio, San Antonio, TX, USA OBJECTIVE: Despite numerous advances in antiretroviral therapy (ART) for HIV patients over the past decade, many patients fail to receive appropriate ART. This study sought to identify demographic factors associated with failure to receive guideline-concordant ART. METHODS: Data was extracted from the 2000-2005 NAMCS. HIV patients were defined as those that received at least one antiretroviral during an ambulatory care visit. Data collected included patient age, gender, race, ethnicity, geographic region, insurance status, and medications. Antiretroviral regimens were evaluated for appropriateness according to antiretroviral guidelines published by the Department of Health and Human Services. Appropriate and inappropriate regimens were compared using the Chi-square or Fisher's Exact test. RESULTS: Antiretroviral therapy was mentioned in 107 of 156,627 visits. These patients had a median (25th-75th percentile) age of 45 (38-54) years, 66% were male, 64% were white, and 42% had Medicaid/SCHIP. Only 58% of patient visits documented appropriate ART. These consisted of two nucleoside reverse transcriptase inhibitors (NRTIs) plus one non-nucleoside reverse transcriptase inhibitor (NNRTI) (36%), two NRTIs plus two protease inhibitors (PIs) (26%), or two NRTIs plus PI (11%). Inappropriate monotherapy was commonly reported: NRTI (30%), PI (16%), or NNRTI (12%) monotherapy. Patients were less likely to receive appropriate therapy if they were Ն50 years of age (23% vs. 49%, p = 0.003) or had Medicare (5% vs. 23%, p = 0.005). All Asian patients in the surveys received inappropriate therapy (p = 0.007 vs. non-Asians). Comparisons of appropriate ART use among females vs. males (30% vs. 47%, p = 0.08) and whites vs. non-whites (63% vs. 67%, p = 0.6); failed to achieve statistical significance. However, the post-hoc power for these statistics was only 42% and 6%, respectively. CONCLUSION: Nearly half of patients in the 2000-2005 NAMCS received suboptimal HIV therapy. Asian patients, Medicare patients, and those patients over the age of 50 years were significantly less likely to receive guideline-endorsed therapies. [1999] [2000] [2001] [2002] [2003] [2004] [2005] . METHODS: This is a cross-sectional database analysis using data from the NAMCS (National ambulatory medical care survey) and NHAMCS (National hospital ambulatory medical care survey) for the years 1999-2005. Records were extracted for office and hospital based physician-patient encounters having a diagnosis of influenza (ICD-9-CM codes 487.0, 487.1, 487.8). The rate of neuraminidase inhibitors (NI) and adamantanes prescribed per 1000 patients with influenza was determined. The association between the type of antiviral drug and the physician specialty, region, patient sex, and patient age was evaluated by adjusted odd ratios. Data were analyzed with Proc logistic regression with adjusted odds ratios by years using SAS® 9.1.3. RESULTS: The prescrib-
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